Vaccine trials ramp up for possible fourth dose in fall with Andrea Garcia, JD, MPH
AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering updates from FDA’s vaccine advisory committee meeting regarding a revised version of the COVID vaccine for fall, the FDA suspending use of a monoclonal antibody drug by GlaxoSmithKline known as sotrovimab to treat high-risk COVID-19 patients in the U.S. because it’s unlikely to be effective against BA.2, and a clinical trial published in NEJM confirms that the anti-parasitic drug, ivermectin, showed no sign of alleviating COVID.
Audio is streamed directly from the publisher (pdst.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.